Amundi Medpace Holdings, Inc. Transaction History

Amundi

$253 Billion
Q2 2024

A detailed history of Amundi transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Amundi holds 16,902 shares of MEDP stock, worth $5.64 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

16,902

Previous 17,273 2.15%

Holding current value

$5.64 Million

Previous $6.98 Million 0.27%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$372.0 - $424.34 $138,012 - $157,430	-371 Reduced 2.15%	16,902 $6.96 Million
Q1 2024 May 15, 2024	BUY	$284.87 - $413.31 $815,867 - $1.18 Million	2,864 Added 19.88%	17,273 $6.98 Million
Q4 2023 Feb 14, 2024	SELL	$227.52 - $312.68 $1.93 Million - $2.65 Million	-8,465 Reduced 37.01%	14,409 $4.42 Million
Q3 2023 Nov 14, 2023	BUY	$233.98 - $281.67 $5 Million - $6.02 Million	21,366 Added 1416.84%	22,874 $5.54 Million
Q1 2023 May 15, 2023	SELL	$174.31 - $239.52 $18,302 - $25,149	-105 Reduced 6.51%	1,508 $283,000
Q4 2022 Feb 14, 2023	SELL	$153.06 - $226.57 $8,418 - $12,461	-55 Reduced 3.3%	1,613 $342,000
Q2 2022 Aug 15, 2022	SELL	$130.2 - $168.03 $21,092 - $27,220	-162 Reduced 8.85%	1,668 $247,000
Q1 2022 May 16, 2022	SELL	$138.87 - $214.31 $49,576 - $76,508	-357 Reduced 16.32%	1,830 $304,000
Q4 2021 Feb 14, 2022	BUY	$182.74 - $227.9 $214,902 - $268,010	1,176 Added 116.32%	2,187 $394,000
Q3 2021 Nov 15, 2021	SELL	$170.18 - $198.21 $6.08 Million - $7.08 Million	-35,708 Reduced 97.25%	1,011 $191,000
Q2 2021 Aug 16, 2021	BUY	$158.62 - $194.3 $5.82 Million - $7.13 Million	36,719 New	36,719 $6.49 Million

Others Institutions Holding MEDP

# of Institutions

654

Shares Held

25.6M

Call Options Held

38.7K

Put Options Held

79.5K

View Full List

About Medpace Holdings, Inc.

Ticker MEDP
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 31,099,900
Market Cap $10.4B
Description
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...

More about MEDP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Amundi, based on Form 13F filings with the SEC.

News

Stay updated on Amundi with notifications on news.

Account